|
|
There are a significant number of debilitating diseases where the therapeutic use
of an interferon inhibitor is strongly indicated.
|
|
Click on the links to the right to learn more about some of our lead indications:
|
|
|
|
|
|
More than 5% of Americans suffer from some form of self-directed immune response.
Approximately 800,000 people in the United States live with HIV infection.
Meiogen holds issued and pending methods patents for the treatment of neurological
diseases, including Down syndrome (US Patent #5,780,027), using interferon inhibition.
The acute and chronic rejection of transplanted organs is a serious limitation to
this life-saving surgery. Our lead compound can help.
|
|